Takeda Pharmaceutical (TAK) Tax Rate (2017 - 2026)
Takeda Pharmaceutical (TAK) posted Tax Rate of 30.4% for Q2 2026, little changed on a QoQ basis from 30.42% in Q1 2026, and down 1290.0% year-over-year from 2.55% in Q2 2025.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Tax Rate (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical has reported Tax Rate for 10 years, with the latest figure at 30.4% in Q2 2026.
- On a quarterly basis, Tax Rate fell 1290.0% year-over-year to 30.4% in Q2 2026; TTM through Jun 2026 was 58.62%, a 3881.0% decrease from a year earlier, with the FY2026 full-year figure at 6.86%, up 4510.0% from the prior year.
- Tax Rate was 30.4% for Q2 2026 at Takeda Pharmaceutical, roughly flat from 30.42% in the prior quarter.
- The five-year high for Tax Rate was 92.9% in Q4 2023, with the low at 41.47% in Q4 2024.
- Average Tax Rate over 5 years is 17.15%, with a median of 30.32% recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Tax Rate jumped 8171 bps in 2023, then tumbled 13437 bps in 2024.
- Over 5 years, Tax Rate stood at 11.2% in 2022, then jumped by 730 bps to 92.9% in 2023, then sank by 145 bps to 41.47% in 2024, then jumped by 54 bps to 19.03% in 2025, then slumped by 60 bps to 30.4% in 2026.
- The last three Tax Rate figures came in at 30.4% (Q2 2026), 30.42% (Q1 2026), and 19.03% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.50 Bn | 622.74 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 440.29 Bn | 433.72 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 364.93 Bn | 357.79 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 266.65 Bn | 258.96 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 158.92 Bn | 147.22 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 44.32 Bn | 44.32 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.78 Bn | 1.57 Bn | 22.08% |
| 9 | United Therapeutics | 21.42 Bn | 18.75 Bn | 683.80 Mn | 10.65% |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.19 Bn | 5.10 Bn | -30.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -30.40% |
| Mar 31, 2026 | -30.42% |
| Dec 31, 2025 | -19.03% |
| Sep 30, 2025 | -30.83% |
| Jun 30, 2025 | -17.49% |
| Mar 31, 2025 | -27.42% |
| Dec 31, 2024 | -41.47% |
| Sep 30, 2024 | -25.18% |
| Jun 30, 2024 | -30.24% |
| Mar 31, 2024 | -33.38% |
| Dec 31, 2023 | 92.90% |
| Sep 30, 2023 | 14.33% |
| Jun 30, 2023 | -33.79% |
| Mar 31, 2023 | -32.48% |
| Dec 31, 2022 | 11.20% |
| Sep 30, 2022 | -4.36% |
| Jun 30, 2022 | -32.45% |
| Mar 31, 2022 | -38.25% |
| Dec 31, 2021 | -19.91% |
| Sep 30, 2021 | -25.15% |